Mercaptopurine is a medication used in the management and treatment of acute lymphoblastic leukemia. It is in the class of medications known as purine antagonists. This activity reviews the indications, action, and contraindications for mercaptopurine as a valuable agent in treating and managing leukemias and inflammatory autoimmune disorders. This activity will highlight the mechanism of action, adverse event profile, and other key factors (e.g., off-label uses, dosing, pharmacodynamics, pharmacokinetics, monitoring, relevant interactions) pertinent for members of the healthcare team in the treatment of patients with acute lymphoblastic leukemia and some inflammatory autoimmune-related conditions.

**Objectives:**
- Identify the mechanism of action and administration of mercaptopurine.
- Describe the potential adverse effects of mercaptopurine.
- Review the appropriate monitoring for patients on mercaptopurine.
- Summarize the interprofessional team strategies for improving care coordination and communication to advance mercaptopurine and improve outcomes.